CFLAR and breast cancer: In addition, TRAIL sensitivity is inversely associated with cellular FLICE-like inhibitory protein (cFLIP) in breast cancer stem cells, as evidenced by the cytotoxicity alleviation in the presence of cFLIP overexpression32.